The gold standard for diagnosing non-IgE CMPA: what the evidence says
The gold standard for diagnosing non-IgE CMPA: what the evidence says
When parents come to me looking for answers about their child's symptoms, one of the first things they ask is: isn't there a test for this? A blood test, a scan, something that gives a definitive answer?
For non-IgE CMPA, there isn't. Not in the way most people expect. What does exist is a diagnostic process that, when done properly, is both reliable and clinically accepted worldwide. This post explains what that process is, why it works, and what the evidence behind it says.
Why there is no standard allergy test for non-IgE CMPA
Standard allergy tests (skin prick tests and RAST blood tests) detect IgE antibodies. These antibodies are produced in IgE-mediated allergic reactions, the immediate, fast-onset type involving hives, swelling, and anaphylaxis.
Non-IgE CMPA involves a different immune mechanism entirely. T-cell mediated responses are responsible for the delayed symptoms parents describe: reflux, eczema, gut disturbance, congestion. Because no IgE antibodies are produced, no IgE test can detect the condition. A negative result does not rule it out.
Some commercially marketed tests claim to identify food sensitivities through IgG testing, hair analysis, or electrodermal screening. The Australian Society of Clinical Allergy and Immunology (ASCIA) does not recommend any of these. The evidence does not support their use for diagnosing food allergy or intolerance, and acting on their results can lead to unnecessary food restrictions, missed diagnoses, and added stress for families (ASCIA, 2023).
What 'gold standard' means in clinical practice
In medicine, a gold standard test is the best available method for diagnosing a condition, against which other tests are measured. It doesn't have to be simple or fast. It has to be accurate.
For non-IgE CMPA, the gold standard is performing a clinical allergy history alongside a supervised dietary elimination of cow's milk protein, followed by a deliberate reintroduction, with careful observation of symptoms during both phases.
This approach is documented in international guidelines including ESPGHAN, ASCIA, BSPGHAN, and the Royal Children's Hospital Melbourne. It is not a fallback used because something better doesn't exist. It is the right test for this type of immune response (ESPGHAN, 2012; BSPGHAN, 2007; ASCIA, 2023; RCH, 2023).
What the guidelines say
ESPGHAN's widely cited 2012 guidelines on CMPA diagnosis and management describe the elimination and reintroduction process as the accepted approach for non-IgE mediated reactions. They recommend a four-week cow's milk protein elimination period followed by a deliberate oral challenge (reintroduction) to confirm the diagnosis.
The guidelines note that symptoms should improve during the elimination phase. Reintroduction should then cause symptom recurrence if the diagnosis is correct. Both observations together constitute a positive diagnostic result. Improvement during elimination alone is not sufficient for confirmation. (ESPGHAN, 2012)
ESPGHAN’s position paper on dietary management of CMPA similarly supports the elimination-reintroduction approach and provides guidance on which foods count as dairy, the duration of exclusion, and how to structure the reintroduction. (Vandenplas, 2024.)
ASCIA guidance for Australian clinicians aligns with these international positions, recommending dietary elimination as the primary diagnostic tool for non-IgE CMPA and advising against unvalidated testing methods. (ASCIA, 2023)
The four-week elimination window: why it matters
Four weeks is the recommended minimum duration for the elimination phase. This isn't arbitrary.
Non-IgE CMPA involves gut inflammation that takes time to settle after the trigger is removed. Some symptoms respond within days: behaviour, sleep, and congestion sometimes improve in the first week or two. Others, particularly eczema and constipation, can take the full four weeks.
An elimination that ends early (say, at two weeks because not much has changed) often produces an inconclusive result. It doesn't mean dairy isn't involved. It means the gut hasn't had enough time to respond. Restarting or extending the elimination is then required, which extends the whole process unnecessarily.
Reintroduction: the confirmation step most people underestimate
The reintroduction phase is where the diagnosis is confirmed. Many families complete the elimination phase, see improvement, and assume the job is done. Technically, a diagnosis of non-IgE CMPA requires the second step too.
Reintroduction is done using fresh dairy, not baked dairy. Fresh dairy (milk, yoghurt) contains the intact milk protein in its most allergenic form. Baked dairy (heated to high temperatures in cooking) is far less allergenic and may not trigger a reaction even in children who are genuinely allergic. Using baked dairy for reintroduction can produce a false negative.
If symptoms return after fresh dairy reintroduction, typically within 72 hours, that is a positive diagnostic result. Non-IgE CMPA is confirmed. (ESPGHAN, 2024). I like to say to families that I feel as sure about the diagnosis as you do. Sometimes you see a reaction in 24 hours and sometimes you need to persist for up to a week (especially with constipation related symptoms). It all depends on how certain you feel. The main thing is during a reintroduction you are monitoring for changes. If you see symptoms returning on day 1 - you can discontinue the reintroduction and return to dairy free. If you are unsure after 3 days, persist until 7 days. If you never see symptoms return then dairy should be continued.
Always follow up with your healthcare provider that is supporting you through this trial to confirm diagnosis as they will have the expertise to monitor subtle symptoms too.
When further investigation is needed
In most cases, a well-conducted elimination and reintroduction is sufficient to reach a diagnosis and begin management. There are situations where further investigation may be warranted.
If symptoms are severe, growth is significantly affected, or symptoms don't resolve despite complete dairy elimination, a referral to a paediatric gastroenterologist may be appropriate. More complex cases may require endoscopy or biopsy, particularly where Eosinophilic Oesophagitis is involved.
If the presentation suggests FPIES (significant vomiting, lethargy, or shock-like response to dairy) rather than non-IgE CMPA, management should be led by an immunologist rather than proceeding to a dietary elimination independently.
For the majority of families with a typical non-IgE CMPA symptom picture, the elimination and reintroduction process, guided by a paediatric dietitian, gives them the diagnosis they need.
Want to understand the process before you start?
Navigating Non-IgE CMPA walks you through the full elimination and reintroduction process, in a version tailored to your baby's feeding situation. Bottle-fed, breastfed, and toddler versions available.